ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drug Eluting Balloons (DEB) Market Research Report 2026
Published Date: 2026-01-21
|
Report Code: QYRE-Auto-21T9094
Home | Market Reports | Health| Medical Devices & Equipment
Global Drug Eluting Balloons DEB Market Outlook 2022
BUY CHAPTERS

Global Drug Eluting Balloons (DEB) Market Research Report 2026

Code: QYRE-Auto-21T9094
Report
2026-01-21
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
B. Braun
Medtronic Inc
Boston Scientific
BD
Philips
Eurocor GmbH
Yinyi Biotechnology
Acotec
Lepu Medical
MicroPort Medical
Teleflex

Drug Eluting Balloons (DEB) Market Size

The global Drug Eluting Balloons (DEB) market was valued at US$ 1520 million in 2025 and is anticipated to reach US$ 3511 million by 2032, at a CAGR of 12.6% from 2026 to 2032.

Drug Eluting Balloons (DEB) Market

Drug Eluting Balloons (DEB) Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drug Eluting Balloons (DEB) competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
A drug-eluting balloon is a non-stent technology in which the effective homogenous delivery of anti-proliferative drugs is processed by the vessel wall through an inflated balloon. This is done to restore luminal vascularity in order to treat atherosclerosis, in-stent restenosis and reduce the risk of late thrombosis without implanting a permanent foreign object. The balloon technology relies on the concept of targeted drug delivery, which helps in the rapid healing of the vessel wall and prevents the proliferation of smooth muscle cells. Drug eluting balloon is a semi-compliant angioplasty balloon, coated with anti-proliferative medicine. The medicine is ejected to the vessel walls during the inflation of the balloon. The balloons are inflated through application of nominal pressure. In 2025, global drug-eluting balloon production reached approximately 1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.
The Drug Eluting Balloons (DEB) market is being driven by the increasing global prevalence of cardiovascular diseases, particularly peripheral artery disease (PAD) and coronary artery disease (CAD). DEBs offer an effective alternative to traditional stents by delivering antiproliferative drugs directly to the vessel wall without leaving a permanent implant, reducing restenosis rates and improving long-term outcomes. Growing patient preference for minimally invasive procedures and shorter recovery times is also contributing to the adoption of DEBs. Furthermore, advancements in drug delivery technologies and increased clinical evidence supporting DEB efficacy are encouraging broader usage, especially among high-risk patients.
Despite their benefits, the DEB market faces several challenges. One key issue is the lack of uniform clinical guidelines and inconsistent results from clinical trials, which may hinder physician confidence and limit widespread adoption. Additionally, the high cost of DEBs compared to conventional balloons or bare-metal stents can be a barrier, particularly in emerging economies with limited healthcare budgets. Regulatory complexities and lengthy approval processes also pose significant hurdles for manufacturers. Furthermore, reimbursement policies vary across regions, creating market access disparities and limiting patient availability to these advanced therapies.
The DEB market is witnessing key trends such as the development of next-generation balloons with enhanced drug coatings and more efficient drug release profiles. There is growing interest in DEBs for treating new indications beyond peripheral and coronary artery disease, such as in-stent restenosis, small vessel disease, and arteriovenous fistula stenosis. Integration of imaging technologies, like intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is also improving procedural outcomes. Additionally, strategic collaborations between medtech companies and research institutions are accelerating innovation, while increasing focus on personalized medicine is expected to drive customized DEB solutions in the near future.
This report delivers a comprehensive overview of the global Drug Eluting Balloons (DEB) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Eluting Balloons (DEB). The Drug Eluting Balloons (DEB) market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drug Eluting Balloons (DEB) market comprehensively. Regional market sizes by Type, by Application, by Use Scenario, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drug Eluting Balloons (DEB) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Drug Eluting Balloons (DEB) Market Report

Report Metric Details
Report Name Drug Eluting Balloons (DEB) Market
Accounted market size in 2025 US$ 1520 million
Forecasted market size in 2032 US$ 3511 million
CAGR 12.6%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Peripheral DEBs
  • Coronary DEBs
Segment by Use Scenario
  • In-Stent Restenosi
  • De Novo
  • Small Vessel
Segment by Balloon Platform Mechanics
  • Semi-/Compliant
  • Non-compliant
  • Other
by Application
  • Catheterization Laboratory
  • Hospital
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, Teleflex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Use Scenario, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Drug Eluting Balloons (DEB) manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Drug Eluting Balloons (DEB) sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Drug Eluting Balloons (DEB) Market growing?

Ans: The Drug Eluting Balloons (DEB) Market witnessing a CAGR of 12.6% during the forecast period 2026-2032.

What is the Drug Eluting Balloons (DEB) Market size in 2032?

Ans: The Drug Eluting Balloons (DEB) Market size in 2032 will be US$ 3511 million.

Who are the main players in the Drug Eluting Balloons (DEB) Market report?

Ans: The main players in the Drug Eluting Balloons (DEB) Market are B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, Teleflex

What are the Application segmentation covered in the Drug Eluting Balloons (DEB) Market report?

Ans: The Applications covered in the Drug Eluting Balloons (DEB) Market report are Catheterization Laboratory, Hospital, Others

What are the Type segmentation covered in the Drug Eluting Balloons (DEB) Market report?

Ans: The Types covered in the Drug Eluting Balloons (DEB) Market report are Peripheral DEBs, Coronary DEBs

1 Drug Eluting Balloons (DEB) Market Overview
1.1 Product Definition
1.2 Drug Eluting Balloons (DEB) by Type
1.2.1 Global Drug Eluting Balloons (DEB) Market Value by Type: 2025 vs 2032
1.2.2 Peripheral DEBs
1.2.3 Coronary DEBs
1.3 Drug Eluting Balloons (DEB) by Use Scenario
1.3.1 Global Drug Eluting Balloons (DEB) Market Value by Use Scenario: 2025 vs 2032
1.3.2 In-Stent Restenosi
1.3.3 De Novo
1.3.4 Small Vessel
1.4 Drug Eluting Balloons (DEB) by Balloon Platform Mechanics
1.4.1 Global Drug Eluting Balloons (DEB) Market Value by Balloon Platform Mechanics: 2025 vs 2032
1.4.2 Semi-/Compliant
1.4.3 Non-compliant
1.4.4 Other
1.5 Drug Eluting Balloons (DEB) by Application
1.5.1 Global Drug Eluting Balloons (DEB) Market Value by Application: 2025 vs 2032
1.5.2 Catheterization Laboratory
1.5.3 Hospital
1.5.4 Others
1.6 Global Drug Eluting Balloons (DEB) Market Size Estimates and Forecasts
1.6.1 Global Drug Eluting Balloons (DEB) Revenue 2021–2032
1.6.2 Global Drug Eluting Balloons (DEB) Sales 2021–2032
1.6.3 Global Drug Eluting Balloons (DEB) Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Drug Eluting Balloons (DEB) Market Competition by Manufacturers
2.1 Global Drug Eluting Balloons (DEB) Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drug Eluting Balloons (DEB) Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drug Eluting Balloons (DEB) Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drug Eluting Balloons (DEB), Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drug Eluting Balloons (DEB), Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drug Eluting Balloons (DEB), Product Types and Applications
2.7 Global Key Manufacturers of Drug Eluting Balloons (DEB), Date of Entry into the Industry
2.8 Global Drug Eluting Balloons (DEB) Market Competitive Situation and Trends
2.8.1 Global Drug Eluting Balloons (DEB) Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drug Eluting Balloons (DEB) Players Market Share by Revenue
2.8.3 Global Drug Eluting Balloons (DEB) Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drug Eluting Balloons (DEB) Market Scenario by Region
3.1 Global Drug Eluting Balloons (DEB) Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drug Eluting Balloons (DEB) Sales by Region: 2021–2032
3.2.1 Global Drug Eluting Balloons (DEB) Sales by Region: 2021–2026
3.2.2 Global Drug Eluting Balloons (DEB) Sales by Region: 2027–2032
3.3 Global Drug Eluting Balloons (DEB) Revenue by Region: 2021–2032
3.3.1 Global Drug Eluting Balloons (DEB) Revenue by Region: 2021–2026
3.3.2 Global Drug Eluting Balloons (DEB) Revenue by Region: 2027–2032
3.4 North America Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.4.1 North America Drug Eluting Balloons (DEB) Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drug Eluting Balloons (DEB) Sales by Country (2021–2032)
3.4.3 North America Drug Eluting Balloons (DEB) Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.5.1 Europe Drug Eluting Balloons (DEB) Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drug Eluting Balloons (DEB) Sales by Country (2021–2032)
3.5.3 Europe Drug Eluting Balloons (DEB) Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drug Eluting Balloons (DEB) Market Facts & Figures by Region
3.6.1 Asia Pacific Drug Eluting Balloons (DEB) Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drug Eluting Balloons (DEB) Sales by Region (2021–2032)
3.6.3 Asia Pacific Drug Eluting Balloons (DEB) Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.7.1 Latin America Drug Eluting Balloons (DEB) Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drug Eluting Balloons (DEB) Sales by Country (2021–2032)
3.7.3 Latin America Drug Eluting Balloons (DEB) Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drug Eluting Balloons (DEB) Market Facts & Figures by Country
3.8.1 Middle East and Africa Drug Eluting Balloons (DEB) Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Drug Eluting Balloons (DEB) Sales by Type (2021–2032)
4.1.1 Global Drug Eluting Balloons (DEB) Sales by Type (2021–2026)
4.1.2 Global Drug Eluting Balloons (DEB) Sales by Type (2027–2032)
4.1.3 Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2021–2032)
4.2 Global Drug Eluting Balloons (DEB) Revenue by Type (2021–2032)
4.2.1 Global Drug Eluting Balloons (DEB) Revenue by Type (2021–2026)
4.2.2 Global Drug Eluting Balloons (DEB) Revenue by Type (2027–2032)
4.2.3 Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2021–2032)
4.3 Global Drug Eluting Balloons (DEB) Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drug Eluting Balloons (DEB) Sales by Application (2021–2032)
5.1.1 Global Drug Eluting Balloons (DEB) Sales by Application (2021–2026)
5.1.2 Global Drug Eluting Balloons (DEB) Sales by Application (2027–2032)
5.1.3 Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2021–2032)
5.2 Global Drug Eluting Balloons (DEB) Revenue by Application (2021–2032)
5.2.1 Global Drug Eluting Balloons (DEB) Revenue by Application (2021–2026)
5.2.2 Global Drug Eluting Balloons (DEB) Revenue by Application (2027–2032)
5.2.3 Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2021–2032)
5.3 Global Drug Eluting Balloons (DEB) Price by Application (2021–2032)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Company Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 B. Braun Drug Eluting Balloons (DEB) Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Medtronic Drug Eluting Balloons (DEB) Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Boston Scientific
6.3.1 Boston Scientific Company Information
6.3.2 Boston Scientific Description and Business Overview
6.3.3 Boston Scientific Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Boston Scientific Drug Eluting Balloons (DEB) Product Portfolio
6.3.5 Boston Scientific Recent Developments/Updates
6.4 BD
6.4.1 BD Company Information
6.4.2 BD Description and Business Overview
6.4.3 BD Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BD Drug Eluting Balloons (DEB) Product Portfolio
6.4.5 BD Recent Developments/Updates
6.5 Yinyi Biotechnology
6.5.1 Yinyi Biotechnology Company Information
6.5.2 Yinyi Biotechnology Description and Business Overview
6.5.3 Yinyi Biotechnology Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Yinyi Biotechnology Drug Eluting Balloons (DEB) Product Portfolio
6.5.5 Yinyi Biotechnology Recent Developments/Updates
6.6 Acotec
6.6.1 Acotec Company Information
6.6.2 Acotec Description and Business Overview
6.6.3 Acotec Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Acotec Drug Eluting Balloons (DEB) Product Portfolio
6.6.5 Acotec Recent Developments/Updates
6.7 Philips
6.7.1 Philips Company Information
6.7.2 Philips Description and Business Overview
6.7.3 Philips Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Philips Drug Eluting Balloons (DEB) Product Portfolio
6.7.5 Philips Recent Developments/Updates
6.8 Lepu Medical
6.8.1 Lepu Medical Company Information
6.8.2 Lepu Medical Description and Business Overview
6.8.3 Lepu Medical Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Lepu Medical Drug Eluting Balloons (DEB) Product Portfolio
6.8.5 Lepu Medical Recent Developments/Updates
6.9 Eurocor
6.9.1 Eurocor Company Information
6.9.2 Eurocor Description and Business Overview
6.9.3 Eurocor Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Eurocor Drug Eluting Balloons (DEB) Product Portfolio
6.9.5 Eurocor Recent Developments/Updates
6.10 MicroPort Medical
6.10.1 MicroPort Medical Company Information
6.10.2 MicroPort Medical Description and Business Overview
6.10.3 MicroPort Medical Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 MicroPort Medical Drug Eluting Balloons (DEB) Product Portfolio
6.10.5 MicroPort Medical Recent Developments/Updates
6.11 Teleflex
6.11.1 Teleflex Company Information
6.11.2 Teleflex Description and Business Overview
6.11.3 Teleflex Drug Eluting Balloons (DEB) Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Teleflex Drug Eluting Balloons (DEB) Product Portfolio
6.11.5 Teleflex Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drug Eluting Balloons (DEB) Industry Chain Analysis
7.2 Drug Eluting Balloons (DEB) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drug Eluting Balloons (DEB) Production Mode & Process Analysis
7.4 Drug Eluting Balloons (DEB) Sales and Marketing
7.4.1 Drug Eluting Balloons (DEB) Sales Channels
7.4.2 Drug Eluting Balloons (DEB) Distributors
7.5 Drug Eluting Balloons (DEB) Customer Analysis
8 Drug Eluting Balloons (DEB) Market Dynamics
8.1 Drug Eluting Balloons (DEB) Industry Trends
8.2 Drug Eluting Balloons (DEB) Market Drivers
8.3 Drug Eluting Balloons (DEB) Market Challenges
8.4 Drug Eluting Balloons (DEB) Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
B. Braun
Medtronic Inc
Boston Scientific
BD
Philips
Eurocor GmbH
Yinyi Biotechnology
Acotec
Lepu Medical
MicroPort Medical
Teleflex
List of Tables
 Table 1. Global Drug Eluting Balloons (DEB) Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Drug Eluting Balloons (DEB) Market Value by Use Scenario (US$ Million), 2025 vs 2032
 Table 3. Global Drug Eluting Balloons (DEB) Market Value by Balloon Platform Mechanics (US$ Million), 2025 vs 2032
 Table 4. Global Drug Eluting Balloons (DEB) Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Drug Eluting Balloons (DEB) Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Drug Eluting Balloons (DEB) Sales (K Units) of Key Manufacturers (2021–2026)
 Table 7. Global Drug Eluting Balloons (DEB) Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Drug Eluting Balloons (DEB) Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Drug Eluting Balloons (DEB) Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Drug Eluting Balloons (DEB) Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Drug Eluting Balloons (DEB), Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Drug Eluting Balloons (DEB), Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Drug Eluting Balloons (DEB), Product Types and Applications
 Table 14. Global Key Manufacturers of Drug Eluting Balloons (DEB), Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Drug Eluting Balloons (DEB) Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug Eluting Balloons (DEB) Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Drug Eluting Balloons (DEB) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Drug Eluting Balloons (DEB) Sales by Region (K Units), 2021–2026
 Table 20. Global Drug Eluting Balloons (DEB) Sales Market Share by Region (2021–2026)
 Table 21. Global Drug Eluting Balloons (DEB) Sales by Region (K Units), 2027–2032
 Table 22. Global Drug Eluting Balloons (DEB) Sales Market Share by Region (2027–2032)
 Table 23. Global Drug Eluting Balloons (DEB) Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Drug Eluting Balloons (DEB) Revenue Market Share by Region (2021–2026)
 Table 25. Global Drug Eluting Balloons (DEB) Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Drug Eluting Balloons (DEB) Revenue Market Share by Region (2027–2032)
 Table 27. North America Drug Eluting Balloons (DEB) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Drug Eluting Balloons (DEB) Sales by Country (K Units), 2021–2026
 Table 29. North America Drug Eluting Balloons (DEB) Sales by Country (K Units), 2027–2032
 Table 30. North America Drug Eluting Balloons (DEB) Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Drug Eluting Balloons (DEB) Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Drug Eluting Balloons (DEB) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Drug Eluting Balloons (DEB) Sales by Country (K Units), 2021–2026
 Table 34. Europe Drug Eluting Balloons (DEB) Sales by Country (K Units), 2027–2032
 Table 35. Europe Drug Eluting Balloons (DEB) Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Drug Eluting Balloons (DEB) Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Drug Eluting Balloons (DEB) Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Drug Eluting Balloons (DEB) Sales by Region (K Units), 2021–2026
 Table 39. Asia Pacific Drug Eluting Balloons (DEB) Sales by Region (K Units), 2027–2032
 Table 40. Asia Pacific Drug Eluting Balloons (DEB) Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Drug Eluting Balloons (DEB) Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Drug Eluting Balloons (DEB) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Drug Eluting Balloons (DEB) Sales by Country (K Units), 2021–2026
 Table 44. Latin America Drug Eluting Balloons (DEB) Sales by Country (K Units), 2027–2032
 Table 45. Latin America Drug Eluting Balloons (DEB) Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Drug Eluting Balloons (DEB) Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (K Units), 2021–2026
 Table 49. Middle East and Africa Drug Eluting Balloons (DEB) Sales by Country (K Units), 2027–2032
 Table 50. Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Drug Eluting Balloons (DEB) Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Drug Eluting Balloons (DEB) Sales (K Units) by Type (2021–2026)
 Table 53. Global Drug Eluting Balloons (DEB) Sales (K Units) by Type (2027–2032)
 Table 54. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2021–2026)
 Table 55. Global Drug Eluting Balloons (DEB) Sales Market Share by Type (2027–2032)
 Table 56. Global Drug Eluting Balloons (DEB) Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Drug Eluting Balloons (DEB) Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2021–2026)
 Table 59. Global Drug Eluting Balloons (DEB) Revenue Market Share by Type (2027–2032)
 Table 60. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Type (2021–2026)
 Table 61. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Type (2027–2032)
 Table 62. Global Drug Eluting Balloons (DEB) Sales (K Units) by Application (2021–2026)
 Table 63. Global Drug Eluting Balloons (DEB) Sales (K Units) by Application (2027–2032)
 Table 64. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2021–2026)
 Table 65. Global Drug Eluting Balloons (DEB) Sales Market Share by Application (2027–2032)
 Table 66. Global Drug Eluting Balloons (DEB) Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Drug Eluting Balloons (DEB) Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2021–2026)
 Table 69. Global Drug Eluting Balloons (DEB) Revenue Market Share by Application (2027–2032)
 Table 70. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Application (2021–2026)
 Table 71. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Application (2027–2032)
 Table 72. B. Braun Company Information
 Table 73. B. Braun Description and Business Overview
 Table 74. B. Braun Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 75. B. Braun Drug Eluting Balloons (DEB) Product
 Table 76. B. Braun Recent Developments/Updates
 Table 77. Medtronic Company Information
 Table 78. Medtronic Description and Business Overview
 Table 79. Medtronic Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 80. Medtronic Drug Eluting Balloons (DEB) Product
 Table 81. Medtronic Recent Developments/Updates
 Table 82. Boston Scientific Company Information
 Table 83. Boston Scientific Description and Business Overview
 Table 84. Boston Scientific Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 85. Boston Scientific Drug Eluting Balloons (DEB) Product
 Table 86. Boston Scientific Recent Developments/Updates
 Table 87. BD Company Information
 Table 88. BD Description and Business Overview
 Table 89. BD Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 90. BD Drug Eluting Balloons (DEB) Product
 Table 91. BD Recent Developments/Updates
 Table 92. Yinyi Biotechnology Company Information
 Table 93. Yinyi Biotechnology Description and Business Overview
 Table 94. Yinyi Biotechnology Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 95. Yinyi Biotechnology Drug Eluting Balloons (DEB) Product
 Table 96. Yinyi Biotechnology Recent Developments/Updates
 Table 97. Acotec Company Information
 Table 98. Acotec Description and Business Overview
 Table 99. Acotec Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 100. Acotec Drug Eluting Balloons (DEB) Product
 Table 101. Acotec Recent Developments/Updates
 Table 102. Philips Company Information
 Table 103. Philips Description and Business Overview
 Table 104. Philips Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 105. Philips Drug Eluting Balloons (DEB) Product
 Table 106. Philips Recent Developments/Updates
 Table 107. Lepu Medical Company Information
 Table 108. Lepu Medical Description and Business Overview
 Table 109. Lepu Medical Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 110. Lepu Medical Drug Eluting Balloons (DEB) Product
 Table 111. Lepu Medical Recent Developments/Updates
 Table 112. Eurocor Company Information
 Table 113. Eurocor Description and Business Overview
 Table 114. Eurocor Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 115. Eurocor Drug Eluting Balloons (DEB) Product
 Table 116. Eurocor Recent Developments/Updates
 Table 117. MicroPort Medical Company Information
 Table 118. MicroPort Medical Description and Business Overview
 Table 119. MicroPort Medical Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 120. MicroPort Medical Drug Eluting Balloons (DEB) Product
 Table 121. MicroPort Medical Recent Developments/Updates
 Table 122. Teleflex Company Information
 Table 123. Teleflex Description and Business Overview
 Table 124. Teleflex Drug Eluting Balloons (DEB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 125. Teleflex Drug Eluting Balloons (DEB) Product
 Table 126. Teleflex Recent Developments/Updates
 Table 127. Key Raw Materials Lists
 Table 128. Raw Materials Key Suppliers Lists
 Table 129. Drug Eluting Balloons (DEB) Distributors List
 Table 130. Drug Eluting Balloons (DEB) Customers List
 Table 131. Drug Eluting Balloons (DEB) Market Trends
 Table 132. Drug Eluting Balloons (DEB) Market Drivers
 Table 133. Drug Eluting Balloons (DEB) Market Challenges
 Table 134. Drug Eluting Balloons (DEB) Market Restraints
 Table 135. Research Programs/Design for This Report
 Table 136. Key Data Information from Secondary Sources
 Table 137. Key Data Information from Primary Sources
 Table 138. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drug Eluting Balloons (DEB)
 Figure 2. Global Drug Eluting Balloons (DEB) Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Drug Eluting Balloons (DEB) Market Share by Type: 2025 & 2032
 Figure 4. Peripheral DEBs Product Picture
 Figure 5. Coronary DEBs Product Picture
 Figure 6. Global Drug Eluting Balloons (DEB) Market Value by Use Scenario (US$ Million), 2021–2032
 Figure 7. Global Drug Eluting Balloons (DEB) Market Share by Use Scenario: 2025 vs 2032
 Figure 8. In-Stent Restenosi Product Picture
 Figure 9. De Novo Product Picture
 Figure 10. Small Vessel Product Picture
 Figure 11. Global Drug Eluting Balloons (DEB) Market Value by Balloon Platform Mechanics (US$ Million), 2021–2032
 Figure 12. Global Drug Eluting Balloons (DEB) Market Share by Balloon Platform Mechanics: 2025 vs 2032
 Figure 13. Semi-/Compliant Product Picture
 Figure 14. Non-compliant Product Picture
 Figure 15. Other Product Picture
 Figure 16. Global Drug Eluting Balloons (DEB) Market Value by Application (US$ Million), 2021–2032
 Figure 17. Global Drug Eluting Balloons (DEB) Market Share by Application: 2025 & 2032
 Figure 18. Catheterization Laboratory
 Figure 19. Hospital
 Figure 20. Others
 Figure 21. Global Drug Eluting Balloons (DEB) Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 22. Global Drug Eluting Balloons (DEB) Market Size (US$ Million), 2021–2032
 Figure 23. Global Drug Eluting Balloons (DEB) Sales (K Units), 2021–2032
 Figure 24. Global Drug Eluting Balloons (DEB) Average Price (US$/Unit), 2021–2032
 Figure 25. Drug Eluting Balloons (DEB) Report Years Considered
 Figure 26. Drug Eluting Balloons (DEB) Sales Share by Manufacturers in 2025
 Figure 27. Global Drug Eluting Balloons (DEB) Revenue Share by Manufacturers in 2025
 Figure 28. Top 5 and Top 10 Global Drug Eluting Balloons (DEB) Players: Market Share by Revenue in Drug Eluting Balloons (DEB) in 2025
 Figure 29. Drug Eluting Balloons (DEB) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 30. Global Drug Eluting Balloons (DEB) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 31. North America Drug Eluting Balloons (DEB) Sales Market Share by Country (2021–2032)
 Figure 32. North America Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021–2032)
 Figure 33. United States Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Canada Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Europe Drug Eluting Balloons (DEB) Sales Market Share by Country (2021–2032)
 Figure 36. Europe Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021–2032)
 Figure 37. Germany Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. France Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. U.K. Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Italy Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Russia Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Asia Pacific Drug Eluting Balloons (DEB) Sales Market Share by Region (2021–2032)
 Figure 43. Asia Pacific Drug Eluting Balloons (DEB) Revenue Market Share by Region (2021–2032)
 Figure 44. China Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Japan Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. South Korea Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. India Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Australia Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. China Taiwan Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Indonesia Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Thailand Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Malaysia Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Latin America Drug Eluting Balloons (DEB) Sales Market Share by Country (2021–2032)
 Figure 54. Latin America Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021–2032)
 Figure 55. Mexico Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Brazil Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Argentina Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Middle East and Africa Drug Eluting Balloons (DEB) Sales Market Share by Country (2021–2032)
 Figure 59. Middle East and Africa Drug Eluting Balloons (DEB) Revenue Market Share by Country (2021–2032)
 Figure 60. Turkey Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. Saudi Arabia Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 62. UAE Drug Eluting Balloons (DEB) Revenue Growth Rate (US$ Million), 2021–2032
 Figure 63. Global Sales Market Share of Drug Eluting Balloons (DEB) by Type (2021–2032)
 Figure 64. Global Revenue Market Share of Drug Eluting Balloons (DEB) by Type (2021–2032)
 Figure 65. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Type (2021–2032)
 Figure 66. Global Sales Market Share of Drug Eluting Balloons (DEB) by Application (2021–2032)
 Figure 67. Global Revenue Market Share of Drug Eluting Balloons (DEB) by Application (2021–2032)
 Figure 68. Global Drug Eluting Balloons (DEB) Price (US$/Unit) by Application (2021–2032)
 Figure 69. Drug Eluting Balloons (DEB) Value Chain
 Figure 70. Channels of Distribution (Direct Vs Distribution)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Drug Eluting Balloon for Peripheral Artery Disease Market Research Report 2024
Global Implantable Drug Eluting Balloon Market Research Report 2024
Global Drug Eluting Balloon for Coronary Artery Disease Market Research Report 2025
Global PTA Drug Eluting Balloons Market Research Report 2025
Global Coronary Drug Coated Balloon Market Research Report 2025
Global Drug Coated Balloon for Peripheral Artery Diseases Market Research Report 2025
Global PTA Drug Coated Balloons Market Research Report 2025
Global Drug Coated Balloon for Coronary Artery Disease Market Research Report 2025
Paclitaxel Drug Eluting Balloon Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon DEB Catheters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Eluting Balloon Catheters Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Coated Balloon Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biodegradable Drug Eluting Stents Market Research Report 2024
Global Peripheral Drug Coated Balloon Market Research Report 2024
Global Biodegradable Polymer Drug eluting Stents BP DES Market Research Report 2024
Global Drug Coated Coronary Balloon Catheter Market Research Report 2024
Global Drug Coated Coronary Balloon Dilatation Catheter Market Research Report 2024
Global Drug Eluting Coronary Stent System Market Research Report 2024
Global Implantable Drug Eluting Stent Market Research Report 2024
Global Peripheral Drug Eluting Stent Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions